Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
CARsgen Therapeutics Receives Orphan Medicinal Product Designation from the European Medicines Agency for CT041 CLDN18.2 CAR T Cells for the Treatment of Gastric Cancers 2021-03-01 19:00
Antengene (6996.HK) Selected as a Constituent Stock of Nine Benchmark and Thematic Indexes Including the Hang Seng Composite Index 2021-03-01 08:00
Alterity to present at the 7th International Congress of Multiple System Atrophy 2021-02-26 20:45
Biocytogen announces acquisition of a third Beacon Optofluidic system to support expanding Antibody Discovery Platform 2021-02-25 23:45
Genome & Company and Debiopharm Join Forces To Create New Highly Specific Therapies for Cancer Patients 2021-02-25 07:00
Alternative meat startup Next Meats Co., Ltd and microalgae biotech company euglena Co., launch "NEXT Euglena Yakiniku EX" containing microalgae 2021-02-24 12:45
GBB Completes USD$3.8M Convertible Note Financing Led by Alibaba Hong Kong Entrepreneurs Fund 2021-02-23 23:00
ABclonal Biotechnology Completes $93 Million Series C Financing 2021-02-22 20:00
GenScript ProBio and Neoletix Announce Successful Completion of 200-Liter GMP Production Runs of Recombinant Coagulation FVIII Based on a Novel Production Technology 2021-02-18 22:00
Bionic Vision Technologies Advances Clinical Program With AU$1 million Medical Research Future Fund Grant 2021-02-17 08:03
Transcenta Holding Announces Appointment of Dr. Michael Shi as Executive Vice President, Head of Global R&D and Chief Medical Officer 2021-02-11 08:00
Alterity Therapeutics announces funding from Michael J. Fox Foundation for ATH434 dose optimization for Parkinson's disease clinical trials 2021-02-09 21:53
Neurophth Closes RMB 400 Million Series B Financing 2021-02-09 21:44
Experiment showed that Jemincare's neutralizing antibody JMB2002 would likely keep the potency against the South African mutant 2021-02-09 11:18
Longevity Acquisition Corporation Announces 4D pharma Clinical Trial Collaboration and Supply Agreement for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma 2021-02-08 21:00
I-Mab Announces Multiple Clinical Advancements of Its Differentiated CD73 Antibody Uliledlimab in China and the U.S. 2021-02-05 21:00
I-Mab Announces First Patient Dosed in Phase 2 Clinical Trial of TJ107 in Glioblastoma Multiforme in China 2021-02-04 21:00
Eucure Biopharma Announces Encouraging Antitumor Activity of Its anti-CD40 Antibody in PD-1 Refractory Ocular Melanoma when Combined with Junshi Biosciences' Toripalimab 2021-02-03 23:45
Dyadic and TurtleTree Scientific enter strategic partnership 2021-02-02 22:00
Clover Biopharmaceuticals Announces Publication of Phase 1 Clinical Trial Data for its Adjuvanted COVID-19 Vaccine Candidates in The Lancet 2021-02-01 14:00
1 92 93 94 95 96 203